RPL36 that also displayed high levels in colon cancer (Figure 3 and Figure 4), has been previously reported to be involved in the early stage of hepatocarcinogenesis; it was expressed in 45 of 60 (75%) HCC by immunohistochemistry, but was not detected in corresponding non-tumors [54]. Here, RPL36 is linked to malignant colon neoplasm.